MORGAN STANLEY - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 137 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$24,518,000
+683.1%
1,396,216
+332.4%
0.00%
Q2 2021$3,131,000
-6.6%
322,876
+3.4%
0.00%
Q1 2021$3,354,000
-18.8%
312,344
+11.2%
0.00%
-100.0%
Q4 2020$4,132,000
+13.5%
280,939
+9.6%
0.00%0.0%
Q3 2020$3,642,000
+178.4%
256,281
+58.6%
0.00%
Q2 2020$1,308,000
+71.2%
161,545
-14.5%
0.00%
Q1 2020$764,000
-60.3%
188,926
-89.9%
0.00%
Q4 2019$1,925,000
+440.7%
1,870,004
+61.2%
0.00%
Q3 2019$356,000
+3.8%
1,160,098
+10.9%
0.00%
Q2 2019$343,000
-32.5%
1,045,698
+35.8%
0.00%
Q1 2019$508,000
-43.2%
769,898
+47.2%
0.00%
Q4 2018$894,000
-56.8%
523,155
+46.7%
0.00%
-100.0%
Q3 2018$2,068,000
+21.0%
356,655
+25.2%
0.00%
Q2 2018$1,709,000
+5.0%
284,795
+26.1%
0.00%
Q1 2018$1,627,000
+39.4%
225,895
+40.4%
0.00%
Q4 2017$1,167,000
+271.7%
160,855
+164.3%
0.00%
Q3 2017$314,000
+982.8%
60,870
+799.1%
0.00%
Q2 2017$29,000
+262.5%
6,770
+383.6%
0.00%
Q1 2017$8,000
+33.3%
1,400
+250.0%
0.00%
Q3 2016$6,000
-86.7%
400
-91.8%
0.00%
Q1 2016$45,000
+309.1%
4,889
+436.1%
0.00%
Q4 2015$11,000
+37.5%
912
+42.7%
0.00%
Q3 2015$8,000
-42.9%
6390.0%0.00%
Q2 2015$14,000
-44.0%
639
-48.9%
0.00%
Q1 2015$25,0001,2500.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
VR Adviser, LLC 4,040,000$59,428,0008.74%
Fairmount Funds Management LLC 1,478,181$21,744,0007.78%
COMMODORE CAPITAL LP 852,871$12,546,0006.82%
Ghost Tree Capital, LLC 1,950,000$28,685,0006.39%
Endurant Capital Management LP 655,741$9,646,0003.48%
FRAZIER MANAGEMENT LLC 3,053,107$44,879,0003.46%
ACUTA CAPITAL PARTNERS, LLC 803,000$11,812,0003.21%
NEA Management Company, LLC 5,736,363$84,382,0002.23%
Tri Locum Partners LP 296,838$4,366,0001.59%
Avidity Partners Management LP 3,185,200$46,854,0001.52%
View complete list of TRILLIUM THERAPEUTICS INC shareholders